English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1143]
News [2510]
Articles [153]
Editorials [8]
Conferences [102]
elearning [18]
Increasing body mass index linked with worse localised prostate cancer outcomes
Increasing body mass index linked with worse localised prostate cancer outcomes
ASCO 2015: Adding chemotherapy to initial therapy extends lives of men with advanced, hormone-naïve prostate cancer
ASCO 2015: Adding chemotherapy to initial therapy extends lives of men with advanced, hormone-naïve prostate cancer
MRI - prostate cancer screening for the future?
MRI - prostate cancer screening for the future?
UK's first proton beam therapy centres will 'transform' cancer care treating more than 2000 patients per year
UK's first proton beam therapy centres will 'transform' cancer care treating more than 2000 patients per year
Unemployment linked to rise in prostate cancer deaths
Unemployment linked to rise in prostate cancer deaths
Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after five years
Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after...
Dutch and US cancer researchers reiterate benefits of exercise for prostate cancer survivors
Dutch and US cancer researchers reiterate benefits of exercise for prostate cancer survivors
AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations
AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations
AACR 2015: Olaparib–carboplatin combination showed early signs of clinical activity against ovarian and triple-negative breast cancers
AACR 2015: Olaparib–carboplatin combination showed early signs of clinical activity against ovarian and triple...
AACR 2015: Subgroup of men with metastatic prostate cancer responded to olaparib treatment
AACR 2015: Subgroup of men with metastatic prostate cancer responded to olaparib treatment
<1...182183184185186...251>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top